Clinical Trial Update: Yulinzhu for Women With Diminished Ovarian Reserve [Phase 3]

View source ↗

Summary

Clinical trial update for a Phase 3 study of Yulinzhu in women with diminished ovarian reserve, currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diminished Ovarian Reserve

Drugs mentioned

• Yulinzhu

Snippet

Sponsor: The University of Hong Kong | Conditions: Diminished Ovarian Reserve (DOR) | Phase 3 | Status: NOT_YET_RECRUITING